Encounter exercise for healthy admintation. Examination and encounter for administrative purposes
Conditions
Interventions
Intervention 1: Control group: Maltodextrin supplementation every day 20 grams (4 times 5 gm) for one week, then every day 5 grams for 8 weeks. Intervention 2: Intervention group: Creatine supplementa
Placebo
Control group: Maltodextrin supplementation every day 20 grams (4 times 5 gm) for one week, then every day 5 grams for 8 weeks
Intervention group: Creatine supplementation every day 20 grams (4 times 5 gm) for one week, then every day 5 grams for 8 weeks
Sponsors
Islamic Azad University, Marivan Branch, Vice Chancellor for research of Islamic Azad University, Ma
Eligibility
Sex/Gender
Male
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: males; nonathletic; aged 40-70 years; healthy; without consume any anti-inflammatory supplementation (during 6 months prior the study). Exclusion criteria: smoking; acute and chronic diseases such as diabetes; renal failure, atherosclerosis and hypertension, muscular injury and distrophy, uncontrolled intake of oxidative and anti-inflammatory drugs supplements and stimulants (during the study).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Caspase-3. Timepoint: pre study, immediately after acute test following one week with or without creatine loading, immediately after acute test following 8 week with or without creatine loading. Method of measurement: ELISA.;Caspase-8. Timepoint: pre study, immediately after acute test following one week with or without creatine loading, immediately after acute test following 8 week with or without creatine loading. Method of measurement: ELISA.;Caspase-9. Timepoint: pre study, immediately after acute test following one week with or without creatine loading, immediately after acute test following 8 week with or without creatine loading. Method of measurement: ELISA.;Caspase-12. Timepoint: pre study, imminently after acute test following one week with or without creatine loading, imminently after acute test following 8 week with or without creatine loading. Method of measurement: ELISA.;IGF-1. Timepoint: pre study, immediately after acute test following one week with or without creatine loading, immediately after acute test following 8 week with or without creatine loading. Method of measurement: ELISA.;P-53. Timepoint: pre study, imminently after acute test following one week with or without creatine loading, imminently after acute test following 8 week with or without creatine loading. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lactate. Timepoint: pre study, immediately after acute test following one week with or without creatine loading, immediately after acute test following 8 week with or without creatine loading. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRahman Rahimi
Univerity of Kurdistan
Outcome results
None listed